Abstracts tagged "Behcet’s syndrome and Work Disability"

Abstract Number: 1788 • 2018 ACR/ARHP Annual Meeting
Predictive Factors for Work-Day Loss in a Multi-Center Study in Behcet’s Disease: Indirect Costs for Healthcare
Haner Direskeneli, Rheumatology, Marmara University, School of Medicine, Istanbul, Turkey
Background/Purpose: In chronic diseases, work-day loss due to health problems is associated with indirect costs for healthcare management. The aim of this multi-center study is…
Abstract Number: 1792 • 2018 ACR/ARHP Annual Meeting
Work Productivity Is Impaired in Patients with Behcet’s Syndrome
Nergis Serin¹, Yesim Ozguler¹, Sinem Nihal Esatoglu¹, Vedat Hamuryudan¹ and Gulen Hatemi², ¹Istanbul University, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, ²Istanbul University Cerrahpasa Medical School, Istanbul, Turkey
Background/Purpose: Behcet’s syndrome (BS) is most active during young adulthood and working years, thus affecting productivity. Work disability was previously reported especially among BS patients…
Abstract Number: 3048 • 2015 ACR/ARHP Annual Meeting
Work Disability over Time in Behcet’s Syndrome
Gulen Hatemi¹, Koray Tascilar², Yesim Ozguler³, Serdal Ugurlu⁴ and Vedat Hamuryudan¹, ¹Rheumatology, Istanbul University, Cerrahpasa Medical School, Istanbul, Turkey, ²Rheumatology, Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey, ³Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, ⁴Rheumatology, Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey
Background/Purpose: Behcet’s syndrome (BS) is most active during young adulthood and may cause severe disability. We had previously observed a high frequency of work disability…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].